Life Science & Biotech

U.S. losing drug-research jobs to other countries

May 17, 2012
Bloomberg News
Eli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore, Ireland and South Africa boost incentives.
More

Indiana slips in life sciences funding

May 14, 2012
J.K. Wall
Indiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies, according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
More

Cancer tools help Roche with Alzheimer's drug

May 13, 2012
Bloomberg News
Treatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs that attack the same protein as Roche’s experimental drug.
More

SCHREIBER: Innovation will drive health care industryRestricted Content

May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
More

BioCrossroads launches second seed fund

April 30, 2012
J.K. Wall
BioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow to the point where they can attract venture capital or a corporate funder.
More

Zimmer profit up slightly, meets expectations

April 26, 2012
Associated Press
Indiana-based orthopedic implant maker Zimmer Holdings Inc. on Thursday reported a fractional increase in first-quarter profit on higher sales in all global regions, particularly the Asia Pacific.
More

Dow Agro sales surge on healthy ag market

April 26, 2012
J.K. Wall
Sales at Indianapolis-based Dow AgroSciences grew 14 percent in the first quarter, to $1.8 billion, helped by an early planting season in North America and a buoyant agricultural market.
More

Purdue set to start building life sciences park

April 19, 2012
Associated Press
The $38 million Lyles-Porter Hall will house numerous health programs. Purdue also is planning a $25 million Drug Discovery Building that will bring together pharmaceutical researchers from throughout the school.
More

Cook Group acquires local biotech company

April 9, 2012
 IBJ Staff
Bloomington-based medical device maker Cook Group has acquired General BioTechnology LLC, an Indianapolis biotech company with about 20 employees, Cook Group announced Monday.
More

New Lilly drug has small sales potential

April 9, 2012
J.K. Wall
Eli Lilly and Co.’s newest drug is a boon for Alzheimer’s research but is likely to bring the Indianapolis drugmaker less than $100 million in annual sales—at least initially, according to one of the few analysts to make a forecast.
More

Biomet offers to acquire DePuy trauma biz for $280M

April 3, 2012
 IBJ Staff and Bloomberg News
Warsaw-based Biomet, which designs and manufactures orthopedic products for surgical and non-surgical uses, said the deal would greatly expand its sports, extremities and trauma business.
More

Roche's downsizing to claim about 80 local IT workers

March 29, 2012
 IBJ Staff
Roche Diagnostics Corp. plans to eliminate about 80 information technology jobs at its Indianapolis-area campus over the next two years, the company said Thursday morning.
More

Device maker Biomet paying $22.7M to settle bribery case

March 26, 2012
Associated Press
Indiana-based Biomet Inc. has agreed to pay $22.7 million to settle U.S. criminal and civil allegations that it bribed government-employed doctors in Argentina, Brazil and China for eight years to win business with hospitals.
More

Q&A

March 26, 2012
J.K. Wall
Tino Pereira, CEO of Canada-based Iotron Industries, discussed the electron-beam facility his company opened March 15 in Columbia City, which lies halfway between Fort Wayne and Warsaw in northern Indiana. Iotron already helps some of the orthopedic implant makers in Warsaw alter the strength, flexibility or surface conditions of the materials in the joint replacements they make. That makes its services important in research and development for new products.
More

Lilly receives Europe's OK for new Byetta use

March 23, 2012
 IBJ Staff and Associated Press, Associated Press
European regulators have approved an expanded use for the diabetes treatment Byetta, developed by Eli Lilly and Co. and Amylin Pharmaceuticals Inc. The FDA approved the same expanded use last fall.
More

Life sciences firm plans to expand, add 46 jobs

March 15, 2012
Noblesville-based Helmer Inc. said it will invest $10.6 million to build a new manufacturing and headquarters facility at the Saxony Corporate Campus near Interstate 69. It plans to add the jobs by 2014.
More

Endocyte pulls trigger on European drug submission

March 13, 2012
J.K. Wall
Endocyte Inc. will submit its ovarian cancer drug EC145 for European market approval in the third quarter of this year after the European Commission granted it orphan drug status.
More

AIT Labs exec succeeding founder Evans as CEO

March 2, 2012
 IBJ Staff
The promotions of several executives follow the Indianapolis-based clinical testing company's announcement in January that it was cutting jobs and restructuring its business.
More

CityWay designed to integrate retail, housing, hotel, YMCARestricted Content

February 25, 2012
Marc D. Allan
Architects were told to push the envelope and integrate. Be mindful of where you are in the city and integrate well.
More

EDITORIAL: BioCrossroads an example of vision at workRestricted Content

February 18, 2012
 IBJ Staff
We hate to think what Indiana’s economic future might be if no one had made a point of putting the state’s life sciences assets to work in a coordinated, strategic way.
More

BioCrossroads has stoked state's life sciences industry, but challenges remainRestricted Content

February 11, 2012
J.K. Wall
In the 10 years BioCrossroads has been promoting life sciences in Indiana, the effort has netted more than 330 new companies, an infusion of more than $330 million in venture capital, a tripling of exports, and a growing number of mentions in national reports on life sciences.
More

Health care VC hits new Indiana low in 2011

February 6, 2012
J.K. Wall
Indiana companies landed just $14.1 million in venture funding last year, the lowest amount of capital flowing to  the state’s health care sector since BioEnterprises began tracking such deals in 2005.
More

Dow Agro posts record fourth quarter profit

February 2, 2012
 IBJ Staff and Associated Press
The Indianapolis-based unit of Dow Chemical Co. saw earnings grow to $142 million, a fourth-quarter record and double the $72 million reported for the 2010 period.
More

Lilly's quarterly profit tumbles, but tops Wall Street estimates

January 31, 2012
J.K. Wall
Patent expirations on Gemzar and Zyprexa contributed to the 27-percent earnings decline, but CEO John Lechleiter touted better-than-expected sales of other products.
More

Purdue hopes center simplifies commercialization

January 30, 2012
J.K. Wall
Purdue University's new Innovation and Commercialization Center is supposed to be a one-stop shop for professors to get help developing their research into products and for outside investors to find out what research is taking place there.
More
Page  1 2 3 4 5 6 7 8 9 10 >> pager
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. we love that we were right in our predictions for the outcome of Tony's boondoggle. We aren't negative, we are positive that the league that never has will continue to blow chunks and stink up the place

  2. I was initially excited to learn that this wasn't rubber-stamped, but if all that is required is to add some shrubs and some "window dressing" over the first floor of the garage, then I'd call it a waste of everyone's time. It should be noted that the Hearing Examiner is a DMD employee who reports to the same administrator as the DMD staff planner who recommended approval of the garage and whose report said that the requirement for ground-floor retail had been "satisfied". Better luck with appealing the inevitable approval at the MDC, where the commissioners are appointed by the Mayor, City Council, and County Commissioners, thus, presumably not all obligated to facilitate the administration's plans.

  3. Wheat Thins, when paired with chocolate ice cream!

  4. About the same.

  5. New airport, new Lucas Oil Stadium, expanded convention center, $30,000,000 Pacer gift, Stupid City Way Project, Broad Ripple Parking Garage $ Giveaway, Money blown on lethal bike lanes. The list is endless..

    We have complete morons in City Government with grafter buddies sitting in the wings also stealing parking meter revenue. Go to
    www.adavceindiana.com and read about Chicago Parking Meter Corruption.

    It's all theft of taxpayer resources and complete lack of financial stewardship and devoid of integrity.

    I would just like for basic city services please.

ADVERTISEMENT